Skip to main content

Market Overview

UPDATE: Morgan Keegan Raises PT on HCP to $43 (HCP)

Share:

Morgan Keegan is out with its report today on HCP (NYSE: HCP), raising its price target from $40 to $43.

In a note to clients, Morgan Keegan writes, "We are raising our estimates. Our 2011 estimates including the prefunding costs related to debt and equity issued in advance of the Manor Care acquisition. We are now excluding them and other transaction costs in line with HCP's guidance. On that basis, we are raising our 2011 FFO estimate $2.60 to $2.63 (guidance $2.58-$2.64) and our FAD estimate from $2.03 to $2.07 (guidance $2.02-$2.08). As a result, we are raising our price target from $40 to $43."

Morgan Keegan has an Outperform rating on shares of HCP.

HCP closed yesterday at $37.52, up 0.78% from Monday's close.

 

Related Articles (HCP)

View Comments and Join the Discussion!

Posted-In: HCP Morgan KeeganAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com